SCHEMBL24835751

SCHEMBL24835751

OCc1ccc(C2CN(Cc3ccccc3)CCN2)cc1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.48
SIGMAR1 Q99720 5/20 0.46
ALDH1A1 P00352 1/20 0.43
CYP2D6 P10635 2/20 0.41
FUCA1 P04066 2/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
GRIN1 Q05586 1/20 0.40
GRIN2B Q13224 1/20 0.40
BCHE P06276 2/20 0.40
ACHE P22303 2/20 0.40
BACE1 P56817 2/20 0.40
S1PR1 P21453 1/20 0.40
S1PR5 Q9H228 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3272931 0.89 SIGMAR1 (0.54) LTA4HSIGMAR1ALDH1A1CYP2D6FUCA1
SCHEMBL3277741 0.89 SIGMAR1 (0.54) LTA4HSIGMAR1ALDH1A1CYP2D6FUCA1
SCHEMBL3272922 0.89 SIGMAR1 (0.54) LTA4HSIGMAR1ALDH1A1CYP2D6FUCA1
SCHEMBL3274123 0.86 SIGMAR1 (0.53) LTA4HSIGMAR1ALDH1A1CYP2D6CYP1A2
SCHEMBL3276041 0.86 SIGMAR1 (0.53) LTA4HSIGMAR1ALDH1A1CYP2D6CYP1A2
SCHEMBL3274127 0.86 SIGMAR1 (0.53) LTA4HSIGMAR1ALDH1A1CYP2D6CYP1A2
Hydrochloric Acid SCHEMBL3278083 0.85 SIGMAR1 (0.51) LTA4HSIGMAR1ALDH1A1CYP2D6CYP1A2
SCHEMBL31235612 0.85 ACHE (0.49) LTA4HSIGMAR1GRIN1GRIN2BBCHE
Hydrochloric Acid SCHEMBL3278090 0.85 SIGMAR1 (0.51) LTA4HSIGMAR1ALDH1A1CYP2D6CYP1A2
SCHEMBL4472074 0.82 BCHE (0.49) LTA4HSIGMAR1ALDH1A1BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed
WO-2023278698-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2023-01-05 WO disclosed
WO-2023278698-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2023-01-05 WO disclosed